Peptides Catalog

Weight Loss Dual GIP/GLP-1 Agonists Multiple Incretin Agonists Gastrointestinal Peptides

Cagrilintida

Cagrilintide, AM833, NNC0174-0833

Cagrilintide is a long-acting acylated amylin analog designed as an agonist of the amylin receptor (AMYR) and the calcitonin gene-related pe…

~1 semana

View full profile Under research

Weight Loss Multiple Incretin Agonists

IBI362, LY3305677, Mazdutide

Mazdutide is a dual GLP-1 and glucagon receptor agonist derived from oxyntomodulin. It combines the appetite reduction and glycemic improvem…

~Varios días (administración semanal)

View full profile Clinical use

GLP-1 Agonists Weight Loss Dual GIP/GLP-1 Agonists Multiple Incretin Agonists Gastrointestinal Peptides

LY3437943, Agonista GGG

Retatrutide is an investigational next-generation triple incretin agonist. It differs from peptides like Semaglutide (GLP-1 agonist) or Tirz…

Aproximadamente 6 días

View full profile Under research

GLP-1 Agonists Weight Loss Dual GIP/GLP-1 Agonists Multiple Incretin Agonists Gastrointestinal Peptides

BI 456906

Survodutide is a novel investigational dual agonist that simultaneously activates GLP-1 and Glucagon (GCG) receptors. Unlike Tirzepatide, wh…

Administración semanal

View full profile Under research

GLP-1 Agonists Weight Loss Dual GIP/GLP-1 Agonists Multiple Incretin Agonists Gastrointestinal Peptides Peptide Hormones

Mounjaro, Zepbound, LY3298176

Tirzepatide is a synthetic dual GIP (gastric inhibitory polypeptide) and GLP-1 receptor agonist approved by the FDA in 2022. It represents t…

~5 días

View full profile Approved